In the latest trading session, 1.31 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.80. With the company’s most recent per share price at $87.94 changed hands at -$0.11 or -0.12% at last look, the market valuation stands at $129.50B. BSX’s current price is a discount, trading about -0.97% off its 52-week high of $88.79. The share price had its 52-week low at $49.15, which suggests the last value was 44.11% up since then. When we look at Boston Scientific Corp.’s average trading volume, we note the 10-day average is 5.54 million shares, with the 3-month average coming to 5.48 million.
Analysts gave the Boston Scientific Corp. (BSX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.51. If we narrow down to specifics, the data shows that 0 out of 15 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 1 recommended BSX as a Hold, 13 felt it is a Buy and 0 rated the stock as Underweight. Boston Scientific Corp.’s EPS for the current quarter is expected to be 0.59.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp. (NYSE:BSX) trade information
Instantly BSX was in red as seen in intraday trades today. With action 1.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 52.12%, with the 5-day performance at 1.35% in the green. However, in the 30-day time frame, Boston Scientific Corp. (NYSE:BSX) is 4.69% up. Looking at the short shares, we see there were 10.92 million shares sold at short interest cover period of 2.07 days.
The consensus price target for the stock as assigned by Wall Street analysts is 78, meaning bulls need a downside of -12.74% from its recent market value. According to analyst projections, BSX’s forecast low is 48 with 118 as the target high. To hit the forecast high, the stock’s price needs a -34.18% plunge from its current level, while the stock would need to tank 45.42% for it to hit the projected low.
Boston Scientific Corp. (BSX) estimates and forecasts
Data shows that the Boston Scientific Corp. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 27.47% over the past 6 months, a 17.07% in annual growth rate that is considerably higher than the industry average of 11.60%. Year-over-year growth is forecast to reach 14.40% up from the last financial year.
Consensus estimates given by 25 financial analysts project the company’s revenue in the current quarter to hit an average of 4.04B. 24 analysts are of the opinion that Boston Scientific Corp.’s revenue for the current quarter will be 4.28B. The company’s revenue for the corresponding quarters a year ago was 3.53B and 3.73B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 14.50%. The estimates for the next quarter sales put growth at 14.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.05%. The 2024 estimates are for Boston Scientific Corp. earnings to increase by 17.49%, but the outlook for the next 5-year period is at 13.00% per year.
BSX Dividends
Boston Scientific Corp. is expected to release its next quarterly earnings report on 2024-Oct-23.
Boston Scientific Corp. (NYSE:BSX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.18% of Boston Scientific Corp. shares while 92.66% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 92.83%. There are 92.66% institutions holding the Boston Scientific Corp. stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 9.6337% of the shares, roughly 141.46 million BSX shares worth $10.89 billion.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 8.8444% or 129.87 million shares worth $10.0 billion as of 2024-06-30.
